Abpro Bio Co., Ltd. (KOSDAQ:195990)

Abpro Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,379	15,495	18,856	16,951	53,961	26,840
Short-Term Investments	3,644	6,119	944.31	796.04	430.25	-
Trading Asset Securities	-	43.43	68.36	4,087	-	4,045
Cash & Short-Term Investments	11,023	21,657	19,869	21,834	54,391	30,885
Cash Growth	39.90%	9.00%	-9.00%	-59.86%	76.11%	106.35%
Accounts Receivable	8,144	10,096	3,994	3,226	2,781	4,085
Other Receivables	865.26	880.07	1,039	325	1,412	625.75
Receivables	11,610	12,261	7,868	4,451	4,193	4,837
Inventory	11,498	13,534	16,432	18,610	15,189	12,664
Prepaid Expenses	-	598.48	37.43	40.62	520.3	564.26
Other Current Assets	1,471	930.47	598.36	857.22	7,610	8,858
Total Current Assets	35,602	48,981	44,804	45,793	81,903	57,808
Property, Plant & Equipment	21,993	21,574	22,579	23,099	24,170	39,552
Long-Term Investments	4,764	43,495	56,413	79,772	57,308	61,656
Goodwill	13,496	13,496	8,004	-	-	-
Other Intangible Assets	3,293	3,338	3,482	2,388	3,621	500.14
Long-Term Accounts Receivable	74.1	112.81	252	-	-	-
Long-Term Deferred Tax Assets	372.57	575.98	125.75	-	-	-
Other Long-Term Assets	9,294	9,331	6,450	5,563	848.94	6,256
Total Assets	89,358	141,263	142,110	156,646	167,884	166,028
Accounts Payable	3,028	6,855	2,127	1,559	2,911	2,227
Accrued Expenses	722.74	652.56	755.34	733.9	478.75	1,682
Short-Term Debt	6,543	8,735	9,249	10,196	21,013	2,495
Current Portion of Long-Term Debt	980.97	971.3	333.16	-	-	-
Current Portion of Leases	401.02	383.92	367.48	303.02	214.43	195.64
Current Income Taxes Payable	5.54	-	7.35	-	-	3.21
Other Current Liabilities	3,430	3,418	5,085	3,217	5,143	8,229
Total Current Liabilities	15,111	21,015	17,925	16,009	29,760	14,831
Long-Term Debt	11,417	11,506	1,294	-	-	8,463
Long-Term Leases	438.14	456.43	550.76	441.24	582.9	241.35
Long-Term Deferred Tax Liabilities	-	213.32	-	-	-	-
Other Long-Term Liabilities	63.1	59.75	-0	0	0	4,294
Total Liabilities	27,029	33,251	19,769	16,450	30,343	27,830
Common Stock	142,345	142,345	142,345	136,845	130,102	125,735
Additional Paid-In Capital	89,786	89,786	89,116	87,288	85,635	83,596
Retained Earnings	-176,197	-128,564	-112,935	-87,193	-79,070	-68,918
Treasury Stock	-2.9	-2.9	-2.9	-2.9	-2.9	-2.9
Comprehensive Income & Other	6,398	4,448	3,817	3,259	876.8	-1,310
Total Common Equity	62,329	108,012	122,340	140,196	137,541	139,100
Minority Interest	-	-	-	-	-	-902.41
Shareholders' Equity	62,329	108,012	122,340	140,196	137,541	138,198
Total Liabilities & Equity	89,358	141,263	142,110	156,646	167,884	166,028
Total Debt	19,781	22,053	11,794	10,940	21,811	11,395
Net Cash (Debt)	-8,758	-395.59	8,075	10,893	32,581	19,491
Net Cash Growth	-	-	-25.88%	-66.56%	67.16%	-
Net Cash Per Share	-30.76	-1.36	29.02	40.60	120.84	90.96
Filing Date Shares Outstanding	284.69	284.69	284.69	273.69	260.2	251.47
Total Common Shares Outstanding	284.69	284.69	284.69	273.69	260.2	251.47
Working Capital	20,491	27,966	26,879	29,783	52,143	42,976
Book Value Per Share	218.94	379.40	429.74	512.25	528.59	553.15
Tangible Book Value	45,540	91,178	110,854	137,808	133,920	138,600
Tangible Book Value Per Share	159.96	320.27	389.39	503.52	514.68	551.17
Land	11,740	11,740	10,000	10,000	10,000	11,475
Buildings	9,664	9,873	18,480	18,494	18,607	26,565
Machinery	5,487	5,499	6,996	7,352	7,218	17,595
Construction In Progress	641.9	14.55	500	-	145.23	148

Source: S&P Global Market Intelligence. Standard template. Financial Sources.